Takeda

TAKHZYRO

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / TAKHZYRO – J0593

Manufacturer:

Takeda

Name:

TAKHZYRO

HCPCS Code Descriptor:

Injection, lanadelumab-flyo, 1 mg (code may be used for medicare when drug administered under direct supervision of a physician, not for use when drug is self-administered)

Category:

J Code

HCPCS:

J0593

NDC(s):

47783-0646-01, 47783-0645-01, 47783-0644-01

Primary Type:

Immunology

Generic Status:

Single-Source

Route of Administration:

Subcutaneous

About:

TAKHZYRO is an Immunology drug manufactured by Takeda and administered via the Subcutaneous route of administration. The J Code: J0593 is aligned to the drug TAKHZYRO.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

10/1/19

HCPCS Effective Date:

10/1/19

HCPCS Short Description:

Inj., lanadelumab-flyo, 1 mg

Billing and Coding Guide:

Not Found

Patient Assistance:

Not Found